Floatz logo

Prilocaine

Postherpetic Neuralgia

NeurogesXSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

18 Active assets in the Postherpetic Neuralgia cohort.

Asset / SponsorPhaseRating
Lidocaine
Seoul National University Hospital
Phase 4BBB
Pregabalin
Neurodawn Pharmaceutical Co., Ltd.
Phase 4BBB
Gabapentin
University of Medicine and Pharmacy at Ho Chi Minh City
Phase 4BBB
Capsaicin
Astellas Pharma Europe Ltd.
Phase 4BBB
(±)-Tramadol
Astellas Pharma Inc
Phase 4BB

View all 50 →

Same molecule, other indications

Prilocaine is also rated in:

amnestic disorderActive
CCC
Indicative · Phase 1/2
52 / 100
View asset →
cognitive disorderActive
CC
Indicative · Phase 1/2
46 / 100
View asset →
goutDormant
D
Indicative · Unknown
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →